KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Opko Health (OPK) Other Operating Expenses (2016 - 2025)

Opko Health's Other Operating Expenses history spans 16 years, with the latest figure at $103.5 million for Q4 2025.

  • For Q4 2025, Other Operating Expenses fell 52.26% year-over-year to $103.5 million; the TTM value through Dec 2025 reached $377.3 million, down 41.26%, while the annual FY2025 figure was $377.3 million, 17.23% down from the prior year.
  • Other Operating Expenses reached $103.5 million in Q4 2025 per OPK's latest filing, up from $19.7 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $375.1 million in Q1 2021 to a low of $5.4 million in Q4 2023.
  • Average Other Operating Expenses over 5 years is $175.8 million, with a median of $159.9 million recorded in 2023.
  • Peak YoY movement for Other Operating Expenses: tumbled 96.33% in 2023, then soared 3914.39% in 2024.
  • A 5-year view of Other Operating Expenses shows it stood at $305.2 million in 2021, then tumbled by 51.81% to $147.1 million in 2022, then crashed by 96.33% to $5.4 million in 2023, then skyrocketed by 3914.39% to $216.8 million in 2024, then crashed by 52.26% to $103.5 million in 2025.
  • Per Business Quant, the three most recent readings for OPK's Other Operating Expenses are $103.5 million (Q4 2025), $19.7 million (Q3 2025), and $126.8 million (Q2 2025).